The money keeps coming for Eli Lilly COVID-19 partner AbCellera with $105M round

Canadian biotech AbCellera has nabbed a meaty $105 million series B funding round as it looks to boost its antibody work and seek out new potential meds against COVID-19.

Its backers are a diverse bunch, from Peter Thiel, PayPal founder and tech/occasional life science investor, to recent partner Eli Lilly, which has helped it become a central figure in the fight against the pandemic and likely did not hurt its ability to raise cash.